QPS has been providing excellence in DMPK services for 25 years. With a focus on Radiolabeled ADME and oligonucleotide studies, QPS provides flexible, response solutions for custom-built DMPK studies.Read More
TOP DOWNLOADED PAPER 2018-2019. Metabolism, Excretion, and Pharmacokinetics of [14C]‐Cefiderocol (S‐649266), a Siderophore Cephalosporin, in Healthy Subjects Following Intravenous Administration.Read More
QPS is celebrating 25 years in business in the year 2020! This year, we have expanded our capabilities to include RT-qPCR (COVID-19) and serological (novel coronavirus antibodies) testing.Read More
Agility. Flexibility. Speed. QPS showcases an animated logo to demonstrate how we embody the unique spirit of the hummingbird.
QPS publishes weekly blog posts to expound on timely and relevant news. Check out our latest series of COVID-19 blog posts!Read More
QPS is working as a contract research organization (CRO) in close collaboration with a large international network of scientists, investigators and professionals. We are operating from strategically located sites throughout Europe, the United States, and Asia Pacific. In every location we focus on selecting the investigators who will be best for your study.
Toxicology, DMPK, Bioanalysis, Gene Therapy, Early and Late Phase Clinical Trials, Recruitment Services and Contract Research Support Services form the backbone of the broad range of QPS service offerings.
QPS offers a comprehensive range of clinical research services. Our support for our pharmaceutical, biotechnology, and CRO partners is unrivaled. As a preclinical CRO, we have the experience and knowledge required to take a pharmaceutical product through the testing phase to clinical trials in a timely manner. The breadth and depth of our drug development offerings are foremost in the industry and we look forward to discussing how we can support your needs.